Dr. Swaraj Bose, MD

Dr. Bose practices at Kapil Gupta MD a Professional Corporation in Los Angeles, California.

Dr. Bose's NPI, 1285714360, was assigned on October 16, 2006. Dr. Bose graduated from All India Institute of Medical Sciences in 1981. Dr. Bose holds California license 000000A65554.

Dr. Bose's primary practice is Kapil Gupta MD a Professional Corporation, at 8631 W 3rd St, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 890-2855.

Dr. Bose's primary practice is Kapil Gupta MD a Professional Corporation in Los Angeles, California. Dr. Bose is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Bose to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bose practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bose's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bose is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Bose is licensed in California.

Dmand AI lists cataract, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma, hypertensive retinopathy and retinal occlusion among the conditions Dr. Bose treats.

CMS data shows 8,552 Medicare services from Dr. Bose across 12 procedure codes in 2024, for 918 Medicare patients. Medicare paid $320,766 for them.

CMS counts 918 Medicare patients who saw Dr. Bose in 2024. The largest group is 75 to 84, with 350 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bose's median patient age at 64, with 63% women.

In 2024, Dr. Bose wrote 1,026 Medicare Part D claims for 238 patients. 75% of them were for generic drugs. CMS names the drug for 870 of them, across 17 drugs with 11 or more claims each, at $58,178 in total drug cost. In 2023, CMS named 721 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bose for performance year 2024, reported individually. Dr. Bose accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Bose, published from 2005 to 2025. 2010 was the busiest year, with 2. The most frequent topics are Biomedical Research, Diagnosis, Differential and Idiopathic Pulmonary Fibrosis. Dr. Bose has published most often in Am J Respir Crit Care Med. Dr. Bose's most frequent co-authors are Justin M. Oldham, MD, Ayodeji O. Adegunsoye and Kevin Robert Flaherty, MD.

Dmand AI links Dr. Bose to 2 clinical trials. Conditions studied include Optic Neuropathy, Ischemic, Pseudotumor Cerebri and Intracranial Hypertension.

CMS Open Payments shows 161 general payments to Dr. Bose from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Horizon Pharma plc paid the most, $27,467.

Dmand AI lists 4 awards for Dr. Bose, most recently Top Doctors:LA Area in 2013.

Dr. Bose graduated from All India Institute of Medical Sciences in 1981. Dr. Bose is a member of AAO.

Dr. Bose is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.